nelfinavir has been researched along with Stroke in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badley, AD; Bennett, SA; Bren, GD; Brenner, C; Deniaud, A; Dong, L; Douen, A; Hardin, H; Hou, ST; Jiang, SX; Kroemer, G; Kroemer, RT; Lallier, J; Lebras, M; Lynch, DH; Moffat, TC; Morin, MY; Phenix, BN; Sim, VL; Tarze, A; van Heeswijk, RP; Weaver, JG; Wettstein, P; Zurakowski, B | 1 |
| Badley, AD; Bennett, SA; Vlahakis, SR; Whitehead, SN | 1 |
1 review(s) available for nelfinavir and Stroke
| Article | Year |
|---|---|
HIV protease inhibitors modulate apoptosis signaling in vitro and in vivo.
Topics: Animals; Apoptosis; Hippocampus; HIV Infections; HIV Protease Inhibitors; Humans; Mitochondrial ADP, ATP Translocases; Nelfinavir; Pancreatitis; Ritonavir; Signal Transduction; Stroke; T-Lymphocytes | 2007 |
1 other study(ies) available for nelfinavir and Stroke
| Article | Year |
|---|---|
Inhibition of adenine nucleotide translocator pore function and protection against apoptosis in vivo by an HIV protease inhibitor.
Topics: Animals; Antibodies; Apoptosis; Disease Models, Animal; Female; Hepatitis; HIV Protease Inhibitors; Humans; Jurkat Cells; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mitochondrial ADP, ATP Translocases; Models, Molecular; Nelfinavir; Ritonavir; Shock, Septic; Signal Transduction; Stroke | 2005 |